BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16909967)

  • 1. Wide local excision and radiotherapy for the treatment of ductal carcinoma in situ of the breast: the Hong Kong experience.
    Yau TK; Chan K; Chant M; Lau HW; Soong IS; Cheung P; Chang AT; Lee AW
    Clin Oncol (R Coll Radiol); 2006 Aug; 18(6):447-52. PubMed ID: 16909967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local recurrence after conservative surgery and radiation therapy for ductal carcinoma in situ: Possible importance of family history.
    Hiramatsu H; Bornstein BA; Recht A; Schnitt SJ; Baum JK; Connolly JL; Duda RB; Guidi AJ; Kaelin CM; Silver EB; Harris JR
    Cancer J Sci Am; 1995; 1(1):55-61. PubMed ID: 9166455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ductal carcinoma in situ of the breast with close or focally involved margins following breast-conserving surgery: treatment with reexcision or radiotherapy with increased dosage.
    Monteau A; Sigal-Zafrani B; Kirova YM; Fourchotte V; Bollet MA; Vincent-Salomon A; Asselain B; Salmon RJ; Fourquet A
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1021-8. PubMed ID: 19386441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.
    Julien JP; Bijker N; Fentiman IS; Peterse JL; Delledonne V; Rouanet P; Avril A; Sylvester R; Mignolet F; Bartelink H; Van Dongen JA
    Lancet; 2000 Feb; 355(9203):528-33. PubMed ID: 10683002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome for mammographically detected ductal carcinoma in situ managed with breast conservation treatment: prognostic significance of reexcision.
    Vapiwala N; Harris E; Hwang WT; Solin LJ
    Cancer J; 2006; 12(1):25-32. PubMed ID: 16613659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast conservation treatment in Hong Kong-early results of 203 patients: retrospective study.
    Yau TK; Lau Y; Kong J; Yeung MW; Chan M; Sze WM; Cheung P; Lim BH; Lee A
    Hong Kong Med J; 2002 Oct; 8(5):322-8. PubMed ID: 12376708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Final results from a multicenter prospective study ( JROSG 05-5) on postoperative radiotherapy for patients with ductal carcinoma in situ with an involved surgical margin or close margin widths of 1 mm or less.
    Shikama N; Sekiguchi K; Nakamura N; Sekine H; Nakayama Y; Imanaka K; Akiba T; Aoki M; Hatayama Y; Ogo E; Kagami Y; Kawashima M; Karasawa K
    J Radiat Res; 2015 Sep; 56(5):830-4. PubMed ID: 26093369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience.
    Sahoo S; Recant WM; Jaskowiak N; Tong L; Heimann R
    Breast J; 2005; 11(4):242-7. PubMed ID: 15982389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five year outcome of 145 patients with ductal carcinoma in situ (DCIS) after accelerated breast radiotherapy.
    Ciervide R; Dhage S; Guth A; Shapiro RL; Axelrod DM; Roses DF; Formenti SC
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e159-64. PubMed ID: 22579378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
    Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of Surgical Margin Status in Ductal Carcinoma In Situ.
    Shaikh T; Li T; Murphy CT; Zaorsky NG; Bleicher RJ; Sigurdson ER; Carlson R; Hayes SB; Anderson P
    Clin Breast Cancer; 2016 Aug; 16(4):312-8. PubMed ID: 26952595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvage treatment for local recurrence following breast-conserving surgery and definitive irradiation for ductal carcinoma in situ (intraductal carcinoma) of the breast.
    Solin LJ; Fourquet A; McCormick B; Haffty B; Recht A; Schultz DJ; Barrett W; Fowble BL; Kuske R; Taylor M
    Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):3-9. PubMed ID: 8083125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study.
    Reitsamer R; Peintinger F; Kopp M; Menzel C; Kogelnik HD; Sedlmayer F
    Strahlenther Onkol; 2004 Jan; 180(1):38-44. PubMed ID: 14704843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study.
    Benitez PR; Streeter O; Vicini F; Mehta V; Quiet C; Kuske R; Hayes MK; Arthur D; Kuerer H; Freedman G; Keisch M; Dipetrillo T; Khan D; Hudes R
    Am J Surg; 2006 Oct; 192(4):427-33. PubMed ID: 16978943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes of hypofractionation versus conventional radiation therapy after breast-conserving surgery for ductal carcinoma in situ of the breast.
    Lalani N; Paszat L; Sutradhar R; Thiruchelvam D; Nofech-Mozes S; Hanna W; Slodkowska E; Done SJ; Miller N; Youngson B; Tuck A; Sengupta S; Elavathil L; Chang MC; Jani PA; Bonin M; Rakovitch E
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1017-24. PubMed ID: 25220719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of clinical and pathologic features with outcome in patients with ductal carcinoma in situ of the breast treated with breast-conserving surgery and radiotherapy.
    Rodrigues N; Carter D; Dillon D; Parisot N; Choi DH; Haffty BG
    Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1331-5. PubMed ID: 12459354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypofractionation Is an Acceptable Alternative to Conventional Fractionation in the Treatment of Postlumpectomy Ductal Carcinoma In Situ With Radiotherapy.
    Isfahanian N; Al-Hajri T; Marginean H; Chang L; Caudrelier JM
    Clin Breast Cancer; 2017 Apr; 17(2):e77-e85. PubMed ID: 27889437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ductal carcinoma in situ (DCIS) treated by mastectomy, or local excision with or without radiotherapy: A monocentric, retrospective study of 608 women.
    Frank S; Dupont A; Teixeira L; Porcher R; De Roquancourt A; Giacchetti S; Espié M; Cuvier C
    Breast; 2016 Feb; 25():51-6. PubMed ID: 26573444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of ductal carcinoma in situ of the breast.
    Reynolds JV; Sweeney JP; Nolan N; Korebrits A; Duffy MJ; McDermott EW; O'Higgins NJ
    Ir J Med Sci; 1993 Feb; 162(2):45-8. PubMed ID: 8383101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subclinical ductal carcinoma in situ of the breast: treatment with conservative surgery and radiotherapy.
    Amichetti M; Caffo O; Richetti A; Zini G; Rigon A; Antonello M; Roncadin M; Coghetto F; Valdagni R; Fasan S; Maluta S; Di Marco A; Neri S; Vidali C; Panizzoni G; Aristei C
    Tumori; 1999; 85(6):488-93. PubMed ID: 10774571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.